Inhibition of nitric oxide synthesis protects the isolated working rabbit heart from ischaemia-reperfusion injury

Cardiovascular Research

Volumn 30, Issue 3, 1995, Pages 432-439

  Schulz, Richard ^a   Wambolt, Richard ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

L Arginine; L NAME; L NMMA; Myocardial ischemia; Nitric oxide; Rabbit heart; Reperfusion; Stunning

Indexed keywords

ARGININE; DEXTRO ARGININE; GLYCOGEN; LACTIC ACID; N(G) METHYLARGININE; N(G) NITROARGININE METHYL ESTER;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEART MUSCLE ISCHEMIA; NONHUMAN; PRIORITY JOURNAL; RABBIT; REPERFUSION INJURY;

ANIMAL; ARGININE; GLYCOGEN; HEART; LACTATES; LACTIC ACID; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; OMEGA-N-METHYLARGININE; PERFUSION; RABBITS; SUPPORT, NON-U.S. GOV'T;

EID: 0029086417     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1016/S0008-6363(95)00064-X     Document Type: Article

References (40)

1. Cocks TM, Angus JA, Campbell JH, Campbell GR. Release and properties of endothelium-derived relaxing factor (EDRF) from endothelial cells in culture. J Cell Physiol 1985;123:310–320.
2. 2+-independent nitric oxide synthase in the myocardium. Br J Pharmacol 1992;105:575–580.
3. Schulz R, Smith JA, Lewis MJ, Moneada S. Nitric oxide synthase in cultured endocardial cells of the pig. Br J Pharmacol 1991;104:21–24.
4. Moneada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993;329:2002–2012.
5. Brady AJB, Warren JB, Poole-Wilson PA, Williams TJ, Harding SE. Nitric oxide attenuates cardiac myocyte contraction. Am J Physiol 1993;265:H176–H182.
6. Shaw AM, Lewis MJ. Modulation of myocardial contraction by endocardial and coronary vascular endothelium. Trends Cardiovasc Med 1993;3:98–103.
7. Balligand J-L, Kelly RA, Marsden PA, Smith TW, Michel T. Control of cardiac muscle function by an endogenous nitric oxide signalling system. Proc Natl Acad Sci USA 1993;90:347–351.
8. Han X, Shimoni Y, Giles WR. An obligatory role for nitric oxide in autonomic control of mammalian heart rate. J Physiol (Lond) 1994;476:309–314.
9. Schulz R, Triggle CR. Role of NO in vascular smooth muscle and cardiac muscle function. Trends Pharmacol Sci 1994;15:255–259.
10. Schulz R, Panas D, Catena R, Moneada S, Olley PM, Lopaschuk GD. The role of nitric oxide in the cardiac depression induced by interleukin-1β and tumour necrosis factor-a. Br J Pharmacol 1995;114:27–34.
11. Patel VC, Yellon DM, Singh KJ, Neild GH, Woolfson RG. Inhibition of nitric oxide limits infarct size in the in situ rabbit heart. Biochem Biophys Res Commun 1993;194:234–238.
12. Siegfried MR, Erhardt J, Rider T, Ma X-L, Lefer AM. Cardioprotection and attenuation of endothelial dysfunction by organic nitric oxide donors in myocardial ischemia-reperfusion. J Pharmacol Exp Ther 1992;260:668–675.
13. Weyrich AS, Ma X-L, Lefer A. The role of l-arginine in ameliorating reperfusion injury after myocardial ischemia in the cat. Circulation 1992;86:279–288.
14. Lopaschuk GD, Belke DD, Gamble J, Itoi T, Schönekess BO. Regulation of fatty acid oxidation in the mammalian heart in health and disease. Biochim Biophys Acta 1994;1213:263–276.
15. Davies NJ, Schulz R, Olley PM, Strynadka KD, Panas DL, Lopaschuk GD. Lysoplasmenylethanolamine accumulation in ischemic/reperfused isolated fatty acid-perfused hearts. Circ Res 1992;70:1161–1168.
16. Rees DD, Palmer RMJ, Schulz R, Hodson HF, Moneada S. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol 1990;101:746–752.
17. Kostic MM, Schrader J. Role of nitric oxide in reactive hyperemia of the guinea pig heart. Circ Res 1992;70:208–212.
18. Barry WH. Calcium and ischemic injury. Trends Cardiovasc Med 1991;1:162–166.
19. Oliver MF, Kurien VA, Greenwood TW. Relation between serum-free-fatty acids and arrhythmias and death after acute myocardial infarction. Lancet 1968;1:710–714.
20. Svensson S, Svedjeholm R, Ekroth R, et al. Trauma metabolism and the heart: uptake of substrates and effects of insulin early after cardiac operations. J Thorac Cardiovasc Surg 1990;99:1063–1073.
21. Depré C, Hue L. Cyclic GMP in the perfused rat heart. Effect of ischaemia, anoxia and nitric oxide synthase inhibitor. FEBS Lett 1994;345:241–245.
22. Zweier JL, Wang P, Kuppusamy P. Direct measurement of nitric oxide generation in the ischemic heart using electron paramagnetic resonance spectroscopy. J Biol Chem 1995;270:304–307.
23. Hibbs JB Jr, Taintor RR, Vavrin Z, et al. Synthesis of nitric oxide from a terminal guanidino nitrogen atom of l-arginine: a molecular mechanism regulating cellular proliferation that targets intracellular iron. In: Moneada S, Higgs EA, eds. Nitric Oxide from L-Arginine: a Bioregulatory System. Amsterdam: Excerpta Medica, 1990:189–224.
24. Rubbo H, Radi R, Trujillo M, et al. Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation. J Biol Chem 1994;269:26066–26075.
25. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990;87:1620–1624.
26. Radi R, Beckman JS, Bush KM, Freeman BA. Peroxynitrite oxidation of sulfhydryls. J Biol Chem 1991;266:4244–4250.
27. Ischiropoulos H, Zhu L, Chen J, et al. Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase. Arch Biochem Biophys 1992;298:431–437.
28. Radi R, Beckman JS, Bush KM, Freeman BA. Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys 1991;288:481–487.
29. Reif DW, Simmons RD. Nitric oxide mediates iron release from ferritin. Arch Biochem Biophys 1990;283:537–541.
30. Radi R, Rodriguez M, Castro L, Telleri R. Inhibition of mitochondrial electron transport by peroxynitrite. Arch Biochem Biophys 1994;308:89–95.
31. Packer MA, Murphy MP. Peroxynitrite causes calcium efflux from mitochondria which is prevented by cyclosporin A. FEBS Lett 1994;345:237–240.
32. Beckman JS, Ye YZ, Anderson PG, et al. Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohisto-chemistry. Biol Chem Hoppe-Seyler 1994;375:81–88.
33. Zweier JL, Kuppusamy P, Williams R, et al. Measurement and characterization of postischemic free radical generation in the isolated perfused heart. J Biol Chem 1989;264:18890–18895.
34. Matheis G, Sherman MP, Buckberg GD, Haybron DM, Young HH, Ignarro LJ. Role of L-arginine-nitric oxide pathway in myocardial reoxygenation injury. Am J Physiol 1992;262:H616–H620.
35. Morita K, Ihnken K, Buckberg GD, Sherman MP, Young HH, Ignarro LJ. Role of controlled cardiac reoxygenation in reducing nitric oxide production and cardiac oxidant damage in cyanotic infantile hearts. J Clin Invest 1994;93:2658–2666.
36. Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 1991;88:4651–4655.
37. Villa LM, Salas E, Darley-Usmar VM, Radomski MW, Moneada S. Peroxynitrite induces both vasodilatation and impaired vascular relaxation in the rat isolated perfused heart. Proc Natl Acad Sci USA 1994;91:12383–12387.
38. Moro MA Darley-Usmar VM, Goodwin DA, et al. Paradoxical fate and biological action of peroxynitrite on human platelets. Proc Natl Acad Sci USA 1994;91:6702–6706.
39. Wink DA, Hanbauer I, Krishna MC, DeGraff W, Gamson J, Mitchell JB. Nitric oxide protects against cellular damage and cytotoxicity from reactive oxygen species. Proc Natl Acad Sci USA 1994;90:9813–9817.
40. Nakashima S, Tohmatsu T, Hattorf H, Okano Y, Nozawa Y. Inhibitory action of cyclic GMP on secretion, polyphosphoinositide hydrolysis and calcium mobilization in thrombin-stimulated human platelets. Biochem Biophys Res Commun 1986:135:1099–1104.